MSWM
SGMO

McGlone Suttner Wealth Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

McGlone Suttner Wealth Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,083
Closed -$6.02K – 182
2024
Q2 		$6.02K Sell
11,083
-155
-1% -$84 ﹤0.01% 163
2024
Q1 		$7.53K Buy
11,238
+155
+1% +$112 ﹤0.01% 167
2023
Q4 		$6.02K Buy
+11,083
New +$5.11K ﹤0.01% 560

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

McGlone Suttner Wealth Management's SGMO Position: Q3 2024 in Review

McGlone Suttner Wealth Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2024, closing a stake of 11,083 shares — an estimated $6.02K sold.

McGlone Suttner Wealth Management first reported a position in SGMO in Q4 2023 and held it in 3 quarters. The position peaked at $7.53K in Q1 2024. 103 funds tracked by Wall St. Rank hold SGMO as of Q3 2024.

  • McGlone Suttner Wealth Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2024 after selling out during the quarter.
  • McGlone Suttner Wealth Management sold 11,083 SANGAMO THERAPEUTICS INC shares in Q3 2024, an estimated $6.02K.
  • McGlone Suttner Wealth Management first reported a position in SANGAMO THERAPEUTICS INC in Q4 2023 and held it in 3 quarters.
  • McGlone Suttner Wealth Management's SANGAMO THERAPEUTICS INC position peaked at $7.53K in Q1 2024.
  • 103 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2024.

Based on McGlone Suttner Wealth Management's 13F filing for Q3 2024, filed 10 Oct 2024.